[HTML][HTML] Immune checkpoint inhibitors: therapeutic advances in melanoma

I Marquez-Rodas, P Cerezuela, A Soria… - Annals of …, 2015 - ncbi.nlm.nih.gov
In recent years, new strategies for treating melanoma have been introduced, improving the
outlook for this challenging disease. One of the most important advances has been the …

[HTML][HTML] Cancer immunotherapy in special challenging populations: recommendations of the Advisory Committee of Spanish Melanoma Group (GEM)

M Gonzalez-Cao, T Puertolas, M Riveiro… - … for ImmunoTherapy of …, 2021 - ncbi.nlm.nih.gov
Cancer immunotherapy based on the use of antibodies targeting the so-called checkpoint
inhibitors, such as programmed cell death-1 receptor, its ligand, or CTLA-4, has shown …

[HTML][HTML] Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial

M Gonzalez-Cao, C Mayo de Las Casas… - Nature …, 2021 - nature.com
Combination treatment with BRAF (BRAFi) plus MEK inhibitors (MEKi) has demonstrated
survival benefit in patients with advanced melanoma harboring activating BRAF mutations …

Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer

EM Ciruelos, MN Díaz, MD Isla, R López… - European journal of …, 2019 - Wiley Online Library
Objectives Although new therapies against metastatic cancer have been developed in
recent decades, chemotherapy is still an important treatment option. Prolonged treatment …

Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patients

M Gonzalez-Cao, MA Basa, T Puertolas, E Muñoz… - MedRxiv, 2020 - medrxiv.org
Background Covid-19 pandemic by the new coronavirus SARS-Cov-2 has produced
devastating effects on the health care system, affecting also cancer patient care. Data about …

Clinicopathologic study of 85 colorectal serrated adenocarcinomas: further insights into the full recognition of a new subset of colorectal carcinoma

J García-Solano, M Pérez-Guillermo… - Human pathology, 2010 - Elsevier
Colorectal serrated adenocarcinoma represents a subtype of colorectal carcinoma that
originates from serrated adenomas. Previous studies have suggested a more aggressive …

Prognostic significance of venous thromboembolic events in disseminated germ cell cancer patients

E Gonzalez-Billalabeitia, D Castellano… - JNCI: Journal of the …, 2017 - academic.oup.com
Background: Disseminated germ cell cancers are at high risk of developing thromboembolic
complications. We evaluated the prognostic value of venous thromboembolic events (VTE) …

Advances in cutaneous melanoma

E Espinosa, A Berrocal, JA López Martín… - Clinical and …, 2012 - Springer
After several decades of slow progress in the field of melanoma, significant advances have
been reported in recent years. These include a better understanding of the molecular …

[HTML][HTML] Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: a retrospective study of the Grupo Espanol Multidisciplinar de Melanoma–Prima study

E Espinosa, V Soriano, J Malvehy, A Berrocal… - Melanoma …, 2016 - journals.lww.com
Adjuvant interferon-α2b (IFN-α2b) has been studied extensively in clinical trials, but there
have been few studies of real-world use. The aim of this study is to describe the IFN-α2b real …

[HTML][HTML] Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study

I Márquez-Rodas, M Martín González, E Nagore… - PLoS …, 2015 - journals.plos.org
Introduction Familial history of melanoma is a well-known risk factor for the disease, and 7%
melanoma patients were reported to have a family history of melanoma. Data relating to the …